Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

Covid-19: A Material Disruptor
Comprehensive review... another BRI mention
https://pharmaboardroom.com/articles/covid-19-a-material-disruptor/
--
Innovation Pharmaceuticals Brilacidin A defensin mimetic drug candidate, as a potential treatment for coronavirus. Brilacidin has shown antibacterial, anti-inflammatory and immunomodulatory properties in several clinical trials
--
will be interesting to see if BRI has direct anti-COVID-19 ability - killing it via puncturing the viral envelope (bleb away), and/or via other antiviral mechanisms... immunomodulatory/anti-inflammatory helping w symptoms (mitigating cytokine storm), resolving secondary infections; any vaccine play is longer but equally intriguing / BRI both as potential Tx and Vax
--
safe and effective... easier to establish when in Phase2
"From a priority standpoint, what we need is safe and effective treatments to combat the viral infection. Limiting further infection will undoubtedly help collective efforts by all. Infected people need treatment. Let’s do our part in supporting the efforts of the biopharmaceutical industry to find effective treatments."